Lea en español

Xarelto (chemical name Rivaroxaban) is an anti-coagulant manufactured by Bayer typically prescribed for people who are at risk for nonhemorrhagic strokes or embolisms. It has also been FDA approved for use during total knee or hip replacement surgery, as well as non-valvular atrial fibrillation. The FDA first approved Rivaroxaban for use in the United States in 2011.
Because it is an anticoagulant, Xarelto poses a serious risk of uncontrolled bleeding, including internal bleeding. At present, there is no known way to reverse the effects of Xarelto, which may be active for 8-12 hours. The FDA has also received reports of liver toxicity tied to use of Xarelto and has required that the package contain a warning not to discontinue without talking to a physician, as the likelihood of stroke can increase dramatically.
If you or someone you love has suffered injury after using Xarelto, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Divorce and Taxes

  If you are facing a divorce, you know that there are plenty of difficult, even painful questi…

07 Dec 2018, Friday

Legalizing Recreational Marijuana: A New State Revolution?

  Election night 2018 brought about several changes in the legal landscape, but probably none s…

06 Dec 2018, Thursday

The State(s) of Medicaid Expansion

  In 2012, the Patient Protection and Affordable Care Act (“ACA”) made some sweeping chang…

05 Dec 2018, Wednesday